Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 4,301–4,325 of 7,816 matching trials · page 173 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Cognitive Training and Brain Stimulation in Prodromal Alzheimer's Disease NCT04265378 anodal tDCS; Intensive cognitive training Runs in: Germany · 1 site |
NA other |
COMPLETED | 46 | University Medicine Greifswald OTHER |
2022-11-04 |
|
Surface EMG to Measure Paratonia in Dementia NCT05606445 Elbow movement |
NA other |
UNKNOWN | 280 | University Medical Center Groningen OTHER |
2022-11-04 |
|
Patient-Centred Innovations for Persons With Multimorbidity - Quebec NCT02789800 DIMAC02 Runs in: Canada · 2 sites |
NA other |
COMPLETED | 284 | Université de Sherbrooke OTHER |
2022-11-03 |
|
Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2) NCT04179721 PES-4-BPSD Model; The attention control condition Runs in: United States · 2 sites |
NA other |
COMPLETED | 54 | Northwell Health OTHER |
2022-11-03 |
|
Synaptic Density and Progression of Huntington's Disease. NCT04701580 11C-UCB-J PET-CT; 18F-FDG PET-MR Runs in: Belgium · 1 site |
NA other |
COMPLETED | 33 | Universitaire Ziekenhuizen KU Leuven OTHER |
2022-11-03 |
|
Effects of Diffused Ylang-Ylang Essential Oil Amongst Older Persons With Dementia NCT05034107 Aromatherapy Runs in: Malaysia · 1 site |
NA other |
COMPLETED | 28 | Universiti Teknologi Mara OTHER |
2022-11-03 |
|
The Effectiveness of a Positive Psychology App in the General Population NCT05292560 Training in positivity Runs in: Netherlands · 1 site |
NA other |
COMPLETED | 250 | University of Twente OTHER |
2022-11-03 |
|
Hyperspectral Retinal Observations for the Cross-sectional Detection of Alzheimer's Disease NCT05604183 non-invasive hyperspectral retinoscopy; blood sample; Test of cogni... Runs in: Sweden · 2 sites |
NA other |
UNKNOWN | 80 | Mantis Photonics AB INDUSTRY |
2022-11-03 |
|
The Dementia Symptom Management at Home Program NCT02482623 Dementia Symptom Management at Home Program Runs in: United States · 2 sites |
NA other |
WITHDRAWN | 0 | New York University OTHER |
2022-11-02 |
|
Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease NCT02728115 Cellavita HD Lower Dose; Cellavita HD Higher dose Runs in: Brazil · 1 site |
PHASE1 other |
UNKNOWN | 6 | Azidus Brasil INDUSTRY |
2022-11-02 |
|
Robot-assisted Cognitive Training for Lonely Older Adults With Mild Cognitive Impairment (MCI) NCT04051918 Piano Training Runs in: United States · 1 site |
NA other |
UNKNOWN | 50 | University of Georgia OTHER |
2022-11-02 |
|
University of Washington Alzheimer's Disease Research Center (UW ADRC) Imaging & Biomarker Core NCT04437290 investigational radiotracer [18F]MK6240 |
NA other |
UNKNOWN | 300 | University of Washington OTHER |
2022-11-02 |
|
GPi+NBM DBS in Parkinson's Disease With Mild Cognitive Impairment NCT04571112 NBM stimulation using the Vercise device (Boston Scientific, Marlbo... Runs in: Canada · 1 site |
NA other |
COMPLETED | 6 | University of Toronto OTHER |
2022-11-02 |
|
Multidomain Intervention on Modifiable Lifestyle Risk Factors for Dementia Prevention NCT05141578 Luci Coach Assisted Intervention Runs in: Canada · 1 site |
NA other |
COMPLETED | 120 | LuciLab INDUSTRY |
2022-11-02 |
|
STRATEGIES to Improve Memory in Alzheimer's Disease NCT04942184 Memory strategies in Arm 1; Electroencephalogram (EEG) headset in A... |
NA other |
WITHDRAWN | 0 | Boston University OTHER |
2022-11-01 |
|
A Clinical Trial of A COVID-19 Vaccine Named Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) NCT04566770 Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector); R... Runs in: China · 1 site |
PHASE2 other |
COMPLETED | 480 | CanSino Biologics Inc. INDUSTRY |
2022-10-31 |
|
Allogeneic Human Mesenchymal Stem Cells for Alzheimer's Disease NCT02833792 Human Mesenchymal Stem Cells and Lactated Riunger's Solution; Placebo Runs in: United States · 1 site |
PHASE2 other |
UNKNOWN | 40 | Stemedica Cell Technologies, Inc. INDUSTRY |
2022-10-28 |
|
Biomarkers of Synaptic Damage in Multiple Sclerosis NCT03217396 lumbar puncture Runs in: Italy · 1 site |
NA other |
RECRUITING | 300 | Neuromed IRCCS OTHER |
2022-10-28 |
|
Clinical Extension Study for Safety and Efficacy Evaluation of Cellavita-HD Administration in Huntington's Patients. NCT04219241 Cellavita-HD Runs in: Brazil · 1 site |
PHASE2|PHASE3 other |
UNKNOWN | 35 | Azidus Brasil INDUSTRY |
2022-10-28 |
|
Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention NCT05407857 multi-modal non-pharmacological intervention Runs in: Taiwan · 1 site |
NA other |
RECRUITING | 380 | Taipei Medical University Shuang Ho Hospital OTHER |
2022-10-28 |
|
Shanghai At Risk for Alzheimer's Disease: a Cohort Study NCT05597410 Runs in: China · 1 site |
NA other |
RECRUITING | 3,418 | Ruijin Hospital OTHER |
2022-10-28 |
|
Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment NCT01300728 NewGam 10% IVIG; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 52 | Sutter Health OTHER |
2022-10-27 |
|
Perfusion by Arterial Spin Labelling Following Single Dose Tadalafil in Small Vessel Disease (PASTIS) Trial NCT02450253 Tadalafil; Placebo; Cognitive functioning tests; Neuropsychological... Runs in: United Kingdom · 1 site |
PHASE2 other |
COMPLETED | 55 | St George's, University of London OTHER |
2022-10-27 |
|
NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) NCT04148391 Placebo Oral Capsule; NYX-458 Runs in: United States · 26 sites |
PHASE2 other |
ACTIVE_NOT_RECRUITING | 99 | Aptinyx INDUSTRY |
2022-10-27 |
|
Filipino Multicomponent Intervention to Maintain Cognitive Performance in High Risk Population (FINOMAIN) NCT04301544 INDAK (Improving Neurocognition through Dance and Kinesthetics); Nu... Runs in: Philippines · 1 site |
NA other |
COMPLETED | 72 | St. Luke's Medical Center, Philippines OTHER |
2022-10-27 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial